Parieto-occipital glucose hypometabolism in Parkinson's disease with autonomic failure.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Journal of Neurological Sciences

• Publication date

  1999-03-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/S0022-510X(99)00011-8PMID 10371072
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Reproducibility of cerebral glucose utilization measured by PET and the [18F]-2-fluoro-2-deoxy-d-glucose method in resting, healthy human subjects

  2004cited by this paper
• Autonomic dysfunction in Parkinson's disease.

  1997cited by this paper
• Disorders affecting autonomic function in parkinsonian patients.

  1996cited by this paper
• Fluoro-deoxyglucose positron emission tomography in diffuse Lewy body disease

  1996cited by this paper
• Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome)

  1996cited by this paper
• Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB)

  1996cited by this paper
• Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy

  1996cited by this paper
• The Metabolic Topography of Normal Aging

  1996cited by this paper
• Disorders affecting autonomic function in parkinsonian patients.

  1996cited by this paper
• Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy. The Consensus Committee of the American Autonomic Society and the American Academy of Neurology.

  1996cited by this paper
• Regional cerebral function determined by FDG-PET in healthy volunteers: normal patterns and changes with age.

  1995cited by this paper
• Positron emission tomography of reversible intellectual impairment induced by long-term anticholinergic therapy.

  1995cited by this paper
• Cortical glucose metabolism in Parkinson's disease without dementia.

  1994cited by this paper
• Intersubject variability of brain glucose metabolic measurements in young normal males.

  1994cited by this paper
• A clinicopathologic study of 100 cases of Parkinson's disease.

  1993cited by this paper
• Clinical and neuropathological aspects of diffuse Lewy body disease in the elderly.

  1993cited by this paper
• Regional cerebral glucose metabolism in patients with Parkinson’s disease with or without dementia

  1992cited by this paper
• Investigation of autonomic disorders

  1992cited by this paper
• Cerebral glucose metabolism in Parkinson's disease with and without dementia.

  1992cited by this paper
• Development of the revised version of Hasegawa's Dementia Scale (HDS-R)

  1991cited by this paper
• Effects of Percent Thresholding on the Extraction of [18F]Fluorodeoxyglucose Positron Emission Tomographic Region-of-Interest Data

  1991cited by this paper
• Positron emission tomography in the differential diagnosis of organic dementias.

  1991cited by this paper
• Diffuse lewy body disease in Japan

  1990cited by this paper
• Antemortem diagnosis of diffuse Lewy body disease

  1990cited by this paper
• Multiple system atrophy--the nature of the beast.

  1989cited by this paper
• Alternative Approach to Single-Scan Estimation of Cerebral Glucose Metabolic Rate Using Glucose Analogs, with Particular Application to Ischemia

  1984cited by this paper
• Patterns of cerebral glucose utilization in Parkinson's disease and Huntington's disease

  1984cited by this paper
• Diffuse type of Lewy body disease: progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree--a new disease?

  1984cited by this paper
• Local cerebral glucose utilisation in treated and untreated patients with Parkinson's disease.

  1984cited by this paper
• The fluorodeoxyglucose 18F scan in Alzheimer's disease and multi-infarct dementia.

  1983cited by this paper
• Cerebral glucose utilization, as measured with positron emission tomography in 21 resting healthy men between the ages of 21 and 83 years.

  1983cited by this paper
• Effects of Human Aging on Patterns of Local Cerebral Glucose Utilization Determined by the [18F] Fluorodeoxyglucose Method

  1982cited by this paper
• THE [14C]DEOXYGLUCOSE METHOD FOR THE MEASUREMENT OF LOCAL CEREBRAL GLUCOSE UTILIZATION: THEORY, PROCEDURE, AND NORMAL VALUES IN THE CONSCIOUS AND ANESTHETIZED ALBINO RAT 1

  1977cited by this paper
• “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician

  1975cited by this paper

• Plasma GFAP and NfL associate with cerebral glucose metabolism in putative brain-first and body-first Parkinson’s disease subtypes

  2025cites this paper
• Pretreatment brain volumes can affect the effectiveness of deep brain stimulation in Parkinson's disease patients

  2020cites this paper
• Parkinson Disease-Related Pattern of Glucose Metabolism Associated With the Potential for Motor Improvement After Deep Brain Stimulation.

  2019cites this paper
• ‘Under pressure’: is there a link between orthostatic hypotension and cognitive impairment in α-synucleinopathies?

  2016cites this paper
• Behavioral and neuroimaging approaches as tools to dissect non-motor manifestations in Parkinson´s Disease: a focus on the visual system

  2015influential citation
• Brain network markers of abnormal cerebral glucose metabolism and blood flow in Parkinson’s disease

  2014cites this paper
• [Neurovisualization in the differential diagnosis of dementia].

  2012cites this paper
• Perfusion and metabolism imaging studies in Parkinson's disease.

  2012cites this paper
• Primary motor cortex of the parkinsonian monkey: differential effects on the spontaneous activity of pyramidal tract-type neurons.

  2011cites this paper
• Biomarkers: Parkinson disease with dementia and dementia with Lewy bodies.

  2010influential citation
• Cortical hypometabolism and hypoperfusion in Parkinson’s disease is extensive: probably even at early disease stages

  2010cites this paper
• Does the Brain Prefer Geometrical Homogeneity?

  2010cites this paper
• Decision Making under Risk Condition in Patients with Parkinson’s Disease: A Behavioural and fMRI Study

  2010cites this paper
• Data-driven intensity normalization of PET group comparison studies is superior to global mean normalization

  2009cites this paper
• Artefactual subcortical hyperperfusion in PET studies normalized to global mean: Lessons from Parkinson's disease

  2009influential citation
• Usefulness of rCBF analysis in diagnosing Parkinson’s disease: supplemental role with MIBG myocardial scintigraphy

  2008cites this paper
• Regional CBF changes in Parkinson’s disease: a correlation with motor dysfunction

  2007cites this paper
• Visual selective attention in Parkinson's disease: dissociation of exogenous and endogenous inhibition.

  2006cites this paper
• For Peer Review

  2005cites this paper
• Positron Emission Tomography and Single-Photon Emission Tomography in the Diagnosis of Parkinson’s Disease Differential Diagnosis From Parkinson-Like Degenerative Diseases

  2005cites this paper
• Positron Emission Tomography and Single-Photon Emission Tomography in the Diagnosis of Parkinson’s Disease

  2005cites this paper
• Neurodegenerative Diseases: PET/SPECT

  2005cites this paper
• Cognitive- and motor-related regions in Parkinson's disease: FDOPA and FDG PET studies

  2004cites this paper
• Primary lateral sclerosis presenting parkinsonian symptoms without nigrostriatal involvement

  2004cites this paper
• Visual hallucination in Parkinson's disease with FDG PET

  2004cites this paper
• Positron emission tomography in clinical neurology.

  2004cites this paper
• Assessing rCBF Changes in Parkinson’s Disease Using Independent Component Analysis

  2003cites this paper
• New insight into the analysis of 6-[18F]fluoro-L-DOPA PET dynamic data in brain tissue without an irreversible compartment: comparative study of the Patlak and Logan analyses.

  2003cites this paper
• Dopaminergic degeneration and perfusional impairment in Lewy body dementia and Alzheimer’s disease

  2003cites this paper
• Alteration of intracellular structure and function of glyceraldehyde-3-phosphate dehydrogenase: a common phenotype of neurodegenerative disorders?

  2002cites this paper
• Resting regional cerebral glucose metabolism in advanced Parkinson's disease studied in the off and on conditions with [18F]FDG‐PET

  2001cites this paper
• Functional brain studies of the neurometabolic bases of cognitive and behavioral changes in Alzheimer's disease

  2001cites this paper
• Hypoperfusion in the supplementary motor area, dorsolateral prefrontal cortex and insular cortex in Parkinson's disease.

  2001cites this paper
• Correlation of intellectual impairment in Parkinson's disease with FDG PET scan

  2000cites this paper